Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03259412
Other study ID # LoughboroughU
Secondary ID
Status Completed
Phase N/A
First received August 4, 2017
Last updated March 26, 2018
Start date January 1, 2016
Est. completion date December 20, 2017

Study information

Verified date March 2018
Source Loughborough University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to determine whether fish oil (specifically omega-3 long chain polyunsaturated fatty acids [EPA-DHA]) supplementation can enhance eccentric resistance exercise performance when combined with a resistance exercise training study. The investigators aim to establish the potential mechanisms that might mediate performance changes at a cellular level.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date December 20, 2017
Est. primary completion date December 20, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Males

- Healthy

Exclusion Criteria:

- Resistance exercise training within the past 6 months

- Vitamin or fish oil supplementation over the past 6 months

- Habitual use of anti-inflammatory drugs

- History of heart disease

- History of coagulation/bleeding disorder

- History of metabolic disease

- Serious allergy

- Known to have blood-borne virus

- Females (Due to differences in cell membrane incorporation of Omega-3 between the sexes and the testing schedule being unable to fit in with menstrual cycle, altering the blood markers that are being measured)

- Currently no symptoms of general illness

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Fish Oil
Fish Oil Capsule
Placebo
Olive Oil capsule manufactured to mimic fish oil capsule

Locations

Country Name City State
United Kingdom Loughborough University Leicester

Sponsors (1)

Lead Sponsor Collaborator
Loughborough University

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Strength Quadriceps and Hamstring strength using an isokinetic dynamometer Change from baseline strength at 11 weeks
Primary Leg power Dynamic leg power assessed through jump height on force platform Change from baseline strength at 11 weeks
See also
  Status Clinical Trial Phase
Completed NCT03205241 - Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance in Healthy Male Cyclists N/A
Completed NCT01775384 - Polyphenols, Exercise, and Metabolomics N/A